ML-347


Catalog No. size PriceQuantity
M6909-2 2mg solid $98
M6909-10 10mg solid $406

Description

Cas:1062368-49-3

Product Information

ML-347, also known as LDN193719, is a potent and selective bone morphogenetic protein receptor (BMP) inhibitor that inhibits ALK1 and ALK2 with IC50 values of 46 and 32 nM, respectively. ML347 shows >300-fold selectivity for ALK2.

 

Chemical Formula: C22H16N4O

 

Exact Mass: 352.1324

 

Molecular Weight: 352.397

 

Elemental Analysis: C, 74.98; H, 4.58; N, 15.90; O, 4.54

 

Synonym:

 

LDN 193719.

 

Chemical Name:

5-(6-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline

 

InChi Key: 

FVRYPYDPKSZGNS-UHFFFAOYSA-N

 

InChi Code: InChI=1S/C22H16N4O/c1-27-17-9-7-15(8-10-17)16-12-24-22-20(13-25-26(22)14-16)18-4-2-6-21-19(18)5-3-11-23-21/h2-14H,1H3

 

Smiles Code:

COC1=CC=C(C(C=N2)=CN3C2=C(C4=CC=CC5=C4C=CC=N5)C=N3)C=C1

 

 

Technical Data:

 

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

 

 

References

 

  1. Engers DW, Frist AY, Lindsley CW, Hong CH, Hopkins CR. Development of a potentand ALK2 selective bone morphogenetic protein receptor (BMP) inhibitor. 2013 Apr12 [updated 2014 Sep 18]. Probe Reports from the NIH Molecular Libraries Program[Internet]. Bethesda (MD): National Center for Biotechnology Information (US);2010-. Available from http://www.ncbi.nlm.nih.gov/books/NBK259191/PubMed PMID: 25506972.

 

  1. Engers DW, Frist AY, Lindsley CW, Hong CC, Hopkins CR. Synthesis andstructure-activity relationships of a novel and selective bone morphogeneticprotein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidinescaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selectiveMLPCN probe. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3248-52. doi:10.1016/j.bmcl.2013.03.113. Epub 2013 Apr 11. PubMed PMID: 23639540; PubMedCentral PMCID: PMC3677712.

 

Products are for research use only. Not for human use.

Payment & Security

American Express Apple Pay Diners Club Discover Elo Google Pay JCB Mastercard PayPal Shop Pay Venmo Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed